首页> 美国卫生研究院文献>other >Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans
【2h】

Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans

机译:多发性硬化症和MR影像学正常的脑扫描患者正常出现的白色物质中谷氨酸和谷氨酰胺的浓度增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In Multiple Sclerosis (MS) the relationship between disease process in normal-appearing white matter (NAWM) and the development of white matter lesions is not well understood. In this study we used single voxel proton ‘Quantitative Magnetic Resonance Spectroscopy’ (qMRS) to characterize the NAWM and thalamus both in atypical ‘Clinically Definite MS’ (CDMS) patients, MRIneg (N = 15) with very few lesions (two or fewer lesions), and in typical CDMS patients, MRIpos (N = 20) with lesions, in comparison with healthy control subjects (N = 20). In addition, the metabolite concentrations were also correlated with extent of brain atrophy measured using Brain Parenchymal Fraction (BPF) and severity of the disease measured using ‘Multiple Sclerosis Severity Score’ (MSSS). Elevated concentrations of glutamate and glutamine (Glx) were observed in both MS groups (MRIneg 8.12 mM, p<0.001 and MRIpos 7.96 mM p<0.001) compared to controls, 6.76 mM. Linear regressions of Glx and total creatine (tCr) with MSSS were 0.16±0.06 mM/MSSS (p = 0.02) for Glx and 0.06±0.03 mM/MSSS (p = 0.04) for tCr, respectively. Moreover, linear regressions of tCr and myo-Inositol (mIns) with BPF were −6.22±1.63 mM/BPF (p<0.001) for tCr and −7.71±2.43 mM/BPF (p = 0.003) for mIns. Furthermore, the MRIpos patients had lower N-acetylaspartate and N-acetylaspartate-glutamate (tNA) and elevated mIns concentrations in NAWM compared to both controls (tNA: p = 0.04 mIns p<0.001) and MRIneg (tNA: p = 0.03 , mIns: p = 0.002). The results suggest that Glx may be an important marker for pathology in non-lesional white matter in MS. Moreover, Glx is related to the severity of MS independent of number of lesions in the patient. In contrast, increased glial density indicated by increased mIns and decreased neuronal density indicated by the decreased tNA, were only observed in NAWM of typical CDMS patients with white matter lesions.
机译:在多发性硬化症(MS)中,正常出现的白质(NAWM)的疾病过程与白质病变的发展之间的关系尚不清楚。在这项研究中,我们使用单个体素质子“定量磁共振波谱”(qMRS)来表征非典型“临床确诊MS”(CDMS)患者,MRIneg(N = 15),病变很少(两个或更少)的NAWM和丘脑病变),在典型的CDMS患者中,与健康对照组相比,MRIpos(N = 20)有病变。此外,代谢物的浓度还与使用脑实质分数(BPF)测得的脑萎缩程度和使用“多发性硬化程度评分”(MSSS)测得的疾病严重程度相关。与对照组6.76 mM相比,在两个MS组中均观察到谷氨酸和谷氨酰胺(Glx)浓度升高(MRIneg 8.12 mM,p <0.001和MRIpos 7.96 mM p <0.001)。 MSl的Glx和总肌酸(tCr)的线性回归分别为glx为0.16±0.06 mM / MSSS(p = 0.02)和tCr为0.06±0.03 mM / MSSS(p = 0.04)。此外,tCr和肌醇与BPF的线性回归对于tCr为-6.22±1.63 mM / BPF(p <0.001),对于mIns为-7.71±2.43 mM / BPF(p = 0.003)。此外,与两个对照组(tNA:p = 0.04 mIns p <0.001)和MRIneg(tNA:p = 0.03,mIns :p = 0.002)。结果表明,Glx可能是MS非病变白质病理的重要标志。此外,Glx与MS的严重程度有关,而与患者的病变数目无关。相反,仅在典型的患有白质病变的CDMS患者的NAWM中观察到由增加的mIns指示的神经胶质密度增加和由tNA减少指示的神经元密度降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号